Log In
BCIQ
Print this Print this
 

Apealea, micellular paclitaxel (Paclical) (OAS-PAC-100)

  Manage Alerts
Collapse Summary General Information
Company Oasmia Pharmaceutical AB
DescriptionCremophor-free formulation of the cytostatic paclitaxel combined with Oasmia's XR-17 excipient technology
Molecular Target Tubulin
Mechanism of ActionMicrotubule stabilization
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

$0.6M

0


 Deals Details
Get a free BioCentury trial today